Pharmacology and therapeutics

Showing results 91 - 100 of 100

Sorted by most recent

TitleAuthorDate

TOP-ID: a Delphi technique-guided development of a prescription and deprescription tool for adults with intellectual disabilities

Sophie Lonchampt, Fabienne Gerber, Jean-Michel Aubry, Jules Desmeules, Marie Besson, Markus Kosel

4 November 2020

Impact of National Drug Pricing Policy 2018 on access to medicines in Lahore division, Pakistan: a pre-post survey study using WHO/HAI methodology

Amna Saeed, Hamid Saeed, Zikria Saleem, Caijun Yang, Minghuan Jiang, Mingyue Zhao, Wenjing Ji, Muhammad Majid Aziz, Faiz Ullah Khan, Ali Hassan Gillani, Naveel Atif, Yu Fang, Zaheer Ud Din Babar

8 October 2020

Nature of adverse events with opioids in hospitalised patients: a post-hoc analysis of three patient record review studies

Bernadette Clara Francisca Maria Schutijser, Irene Jongerden, Joanna Ewa Klopotowska, Marco Moesker, Maaike Langelaan, Cordula Wagner, Martine de Bruijne

30 September 2020

Predictors of oral anticoagulant-associated adverse events in seniors transitioning from hospital to home: a retrospective cohort study protocol

Harsukh Benipal, Anne Holbrook, J. Michael Paterson, James Douketis, Gary Foster, Lehana Thabane

22 September 2020

Christian Ulrich Eriksen, Stavros Kyriakidis, Line Due Christensen, Ramune Jacobsen, Jannie Laursen, Mikkel Bring Christensen, Anne Frølich

6 September 2020

Adverse effects information in clinical guidelines on pharmacological treatment of depression in children and adolescents: a systematic review

Tone Westergren, Sigrid Narum, Marianne Klemp

20 July 2020

Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study

Thomas J Moore, James Heyward, Gerard Anderson, G Caleb Alexander

11 June 2020

Chinese physicians’ attitudes toward eco-directed sustainable prescribing from the perspective of ecopharmacovigilance: a cross-sectional study

Jun Wang, Shulan Li, Bingshu He

1 June 2020

Cannabidiol (CBD) and Δ-tetrahydrocannabinol (THC) for chronic insomnia disorder (‘CANSLEEP’ trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial

Anastasia Suraev, Ronald R Grunstein, Nathaniel S Marshall, Angela L D'Rozario, Christopher J Gordon, Delwyn J Bartlett, Keith Wong, Brendon J Yee, Ryan Vandrey, Chris Irwin, Jonathon C Arnold, Iain S McGregor, Camilla M Hoyos

18 May 2020

Are monitoring instructions provided in direct healthcare professional communications (DHPCs) of sufficient quality? A retrospective analysis of DHPCs sent out between 2007 and 2018

Maja-Marie Grønfeldt Højer, Marie Louise De Bruin, Arnela Boskovic, Christine Erikstrup Hallgreen

11 May 2020

Prev 1 2 3 4 5 6 7 8 910